1. Home
  2. GEHC vs FNV Comparison

GEHC vs FNV Comparison

Compare GEHC & FNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEHC
  • FNV
  • Stock Information
  • Founded
  • GEHC 1892
  • FNV 1986
  • Country
  • GEHC United States
  • FNV Canada
  • Employees
  • GEHC N/A
  • FNV N/A
  • Industry
  • GEHC Computer Software: Prepackaged Software
  • FNV Precious Metals
  • Sector
  • GEHC Technology
  • FNV Basic Materials
  • Exchange
  • GEHC Nasdaq
  • FNV Nasdaq
  • Market Cap
  • GEHC 34.8B
  • FNV 32.5B
  • IPO Year
  • GEHC N/A
  • FNV 2007
  • Fundamental
  • Price
  • GEHC $75.13
  • FNV $159.86
  • Analyst Decision
  • GEHC Strong Buy
  • FNV Buy
  • Analyst Count
  • GEHC 10
  • FNV 8
  • Target Price
  • GEHC $89.10
  • FNV $169.00
  • AVG Volume (30 Days)
  • GEHC 3.8M
  • FNV 784.9K
  • Earning Date
  • GEHC 07-30-2025
  • FNV 08-11-2025
  • Dividend Yield
  • GEHC 0.19%
  • FNV 0.93%
  • EPS Growth
  • GEHC 38.77
  • FNV N/A
  • EPS
  • GEHC 4.76
  • FNV 3.21
  • Revenue
  • GEHC $19,799,000,000.00
  • FNV $1,212,000,000.00
  • Revenue This Year
  • GEHC $5.19
  • FNV $28.02
  • Revenue Next Year
  • GEHC $4.71
  • FNV $19.06
  • P/E Ratio
  • GEHC $15.78
  • FNV $49.75
  • Revenue Growth
  • GEHC 1.56
  • FNV 1.33
  • 52 Week Low
  • GEHC $57.65
  • FNV $112.70
  • 52 Week High
  • GEHC $94.80
  • FNV $179.99
  • Technical
  • Relative Strength Index (RSI)
  • GEHC 56.35
  • FNV 41.35
  • Support Level
  • GEHC $74.38
  • FNV $156.97
  • Resistance Level
  • GEHC $77.32
  • FNV $166.58
  • Average True Range (ATR)
  • GEHC 1.63
  • FNV 3.35
  • MACD
  • GEHC 0.11
  • FNV -0.70
  • Stochastic Oscillator
  • GEHC 72.03
  • FNV 21.94

About GEHC GE HealthCare Technologies Inc.

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

About FNV Franco-Nevada Corporation

Franco-Nevada Corp is a precious-metals-focused royalty and investment company. The company owns a diversified portfolio of precious metals and royalty streams, which is actively managed to generate the bulk of its revenue from gold, silver, and platinum. The company does not operate mines, develop projects, or conduct exploration. Franco-Nevada's short-term financial performance is linked to the price of commodities and the amount of production from its portfolio of producing assets. Its long-term performance is affected by the availability of exploration and development capital. The company holds a portfolio of assets, diversified by commodity, revenue type, and stage of a project, located in the U.S, Canada, and Australia.

Share on Social Networks: